Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Depreciation & Amortization (CF) of $706000.0 for Q1 2026, down 10.63% sequentially from $790000.0 in Q4 2025, and down 16.65% YoY from $847000.0 in Q1 2025.
Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $706000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 16.65% year-over-year to $706000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 8.58% YoY) and the FY2025 annual result came in at $3.3 million, down 3.27% from the prior year.
- Depreciation & Amortization (CF) slipped to $706000.0 in Q1 2026 per RPID's latest filing, from $790000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $869000.0 in Q4 2024 and troughed at $560000.0 in Q1 2022.
- A 5-year average of $780117.6 and a median of $794000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) surged 127.67% in 2022, then decreased 16.65% in 2026.
- Over 5 years, Depreciation & Amortization (CF) stood at $860000.0 in 2022, then retreated by 7.67% to $794000.0 in 2023, then increased by 9.45% to $869000.0 in 2024, then dropped by 9.09% to $790000.0 in 2025, then declined by 10.63% to $706000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $706000.0, $790000.0, and $804000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | 674,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 674,000.00 |
| Jun 30, 2026 | 674,000.00 |
| Mar 31, 2026 | 706,000.00 |
| Mar 31, 2026 | 706,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Mar 31, 2024 | 806,000.00 |